This inventor holds 1 USPTO granted patent. Top assignee: Medtronic Ireland Manufacturing Unlimited Company. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Spotlight on Inventor Marcia Gallagher: Pioneering PTSD Treatment Innovations
Introduction
Marcia Gallagher, an innovative inventor based in Galway, Ireland, has made significant contributions to the field of medical technology. Her pioneering work has led to the development of a groundbreaking method for treating post-traumatic stress disorder (PTSD) through renal neuromodulation. With a focus on enhancing patient outcomes, Gallagher's inventions are making a difference in the lives of those affected by PTSD.
Latest Patents
Gallagher holds a patent titled "Methods for treating post-traumatic stress disorder in patients via renal neuromodulation." This patented method details approaches to treat PTSD and reduce the risk of developing it through therapeutic interventions targeting renal sympathetic nerve activities. The technology presented in her patent includes utilizing intravascular catheters equipped with therapeutic assemblies that employ electrically-induced, thermally-induced, or chemically-induced techniques to modulate renal sympathetic nerves. The innovations focus on improving patients' calculated risk scores related to PTSD status and addressing associated risk factors, marking a significant advancement in PTSD treatment options.
Career Highlights
Marcia Gallagher is currently affiliated with Medtronic Ireland Manufacturing Unlimited Company, where her work is focused on advancing medical technologies. Her commitment to enhancing mental health treatment illustrates her dedication to improving patient care through innovative solutions. Gallagher's achievements reflect her role as a leading inventor in her field, contributing meaningful advancements to the medical community.
Collaborations
In her career, Gallagher has worked alongside her colleague, Douglas A Hettrick. Collaborations with fellow innovative minds in the industry have played a crucial role in the development of her techniques and patents. Working together, they have been able to explore and expand the possibilities of renal neuromodulation as a valid treatment for PTSD.
Conclusion
Marcia Gallagher's contributions to medical technology through her patent on PTSD treatment exemplify her ingenuity as an inventor. Her work at Medtronic Ireland Manufacturing Unlimited Company not only highlights her skills but also her commitment to making a lasting impact in the field of mental health. As innovations continue to emerge in the realm of PTSD treatment, Gallagher's pioneering research serves as an inspiration for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile